SUBSCRIBE
SUBSCRIBE

Spark Therapeutics

NEWS
FDA
Second CAR-T Approval Points to Exciting Times for Gene Therapy
Big pharmas are having a good year so far in terms of FDA approvals.
October 23, 2017
 · 
1 min read
 · 
Karl Thiel
Novartis Has Set a Tricky Precedent in Gene Therap
FDA
Novartis Has Set a Tricky Precedent in Gene Therapy
A look at how the gene therapy approvals may end up confusing payers, lawmakers, and the general public at a time when the industry desperately needs clarity.
October 19, 2017
 · 
5 min read
 · 
Karl Thiel
3 Biotechs That Got Huge Boosts From Spark's FDA P
Pharm Country
3 Biotechs That Got Huge Boosts From Spark’s FDA Panel Vote
On Oct. 13, the FDA’s Cellular, Tissue and Gene Therapies Advisory Committee unanimously recommended Spark’s Luxturna in a vote of 16 to 0.
October 17, 2017
 · 
2 min read
 · 
Mark Terry
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Policy
Spark Therapeutics Jumps as FDA Panel Backs Breakthrough Gene Therapy
The FDA’s Cellular, Tissue and Gene Therapies Advisory Committee unanimously recommended Spark’s Luxturna in a vote of 16 to 0.
October 13, 2017
 · 
2 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Policy
Spark Therapeutics’ Revolutionary Gene Therapy for Blindness Faces the FDA on Thursday
October 10, 2017
 · 
3 min read
Pharm Country
Why You Shouldn’t Fear Spark Therapeutics’ Upcoming Share Issue
August 7, 2017
 · 
1 min read
Pharm Country
Spark Therapeutics: The Next Big Thing In Gene Therapy?
May 26, 2017
 · 
1 min read
Tiny KalVista Explodes on $760 Million Deal With Drug Giant Merck & Co.
Business
Massachusetts’ Selecta Wrangles $890 Million+ R&D Deal Out of Spark Therapeutics
December 5, 2016
 · 
3 min read
How Biogen Makes Most of Its Cash
Business
Biogen Taps Former Spark Therapeutics Exec and a Finance Vet for Hemophilia Spin-off Company Bioverativ
November 15, 2016
 · 
3 min read
Load More
AWARDS
  • NextGen Class of 2015
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Business
Spark Therapeutics Reports Full Year 2014 Financial Results
March 18, 2015
 · 
10 min read
Pharm Country
Spark Therapeutics To Participate In The 35th Annual Cowen and Company Health Care Conference
February 26, 2015
 · 
3 min read
Pharm Country
Spark Therapeutics Announces Closing of Its Initial Public Offering
February 4, 2015
 · 
2 min read
Deals
Spark Therapeutics Announces Pricing of Its Initial Public Offering
January 30, 2015
 · 
2 min read
Drug Development
Spark Therapeutics Initiates Phase 1/2 Clinical Trial Of SPK-CHM For Choroideremia, Expanding Its Pipeline Of Potential Treatments For Rare, Blinding Conditions
January 20, 2015
 · 
5 min read
Business
Spark Therapeutics Appoints Rare Disease Pioneer Dr. Rogerio Vivaldi As Chief Commercial Officer
December 16, 2014
 · 
4 min read
Business
Spark Therapeutics Appoints Former Chief Of U.S. FDA’s Gene Therapy Branch As Its Head Of Regulatory Affairs
November 25, 2014
 · 
3 min read
Drug Development
Spark Therapeutics Snags FDA Breakthrough Therapy Designation For Lead Product
November 6, 2014
 · 
4 min read
Business
Spark Therapeutics Appoints Industry Leaders Lars Ekman And Vin Milano To Board Of Directors
June 16, 2014
 · 
5 min read
Pharm Country
Children’s Hospital of Philadelphia Gene-Therapy Spinout Spark Therapeutics Hauls In $72.8 Million
May 28, 2014
 · 
3 min read
Load More